Macular Degeneration News and Research

Latest Macular Degeneration News and Research

DMEI dedicates new $46M research and clinical facility

DMEI dedicates new $46M research and clinical facility

Novel bipartite gene therapy for retinitis pigmentosa

Novel bipartite gene therapy for retinitis pigmentosa

DSMB authorizes ACT to proceed with next set of patients in stem cell clinical trials

DSMB authorizes ACT to proceed with next set of patients in stem cell clinical trials

ACT receives UK MHRA clearance for hESC-derived RPE cell trial for Stargardt's Macular Dystrophy

ACT receives UK MHRA clearance for hESC-derived RPE cell trial for Stargardt's Macular Dystrophy

Silence Therapeutics reports revenue of £354,078 for six months ended 30 June 2011

Silence Therapeutics reports revenue of £354,078 for six months ended 30 June 2011

ERWW PR forms Health Buzz Group

ERWW PR forms Health Buzz Group

New collaboration reinforces Sanofi's translational discovery platform for retinal diseases

New collaboration reinforces Sanofi's translational discovery platform for retinal diseases

Lucentis receives Health Canada approval to treat vision loss from DME

Lucentis receives Health Canada approval to treat vision loss from DME

Discovery in rare disease may shed light on common causes of blindness

Discovery in rare disease may shed light on common causes of blindness

Insight into molecular basis of Enhanced S-Cone Syndrome

Insight into molecular basis of Enhanced S-Cone Syndrome

Seven research teams across the U.S. to develop new drugs for nervous system disorders

Seven research teams across the U.S. to develop new drugs for nervous system disorders

NIH/NINDS awards AMRI to develop pre-clinical drug candidate for spinal muscular atrophy

NIH/NINDS awards AMRI to develop pre-clinical drug candidate for spinal muscular atrophy

Lucentis receives Health Canada approval for treatment of retinal vein occlusion

Lucentis receives Health Canada approval for treatment of retinal vein occlusion

La Jolla Institute's new RNAi Center to focus on genetics behind myriad diseases

La Jolla Institute's new RNAi Center to focus on genetics behind myriad diseases

Single engineered protein blocks two related angiogenic receptors

Single engineered protein blocks two related angiogenic receptors

Researchers team up to combat age-related macular degeneration

Researchers team up to combat age-related macular degeneration

Early detection critical in preventing vision loss among Baby Boomers

Early detection critical in preventing vision loss among Baby Boomers

New convenient device can track degenerative eye disease

New convenient device can track degenerative eye disease

Inotek completes two stages of INO-8875 Phase 2b trial against glaucoma

Inotek completes two stages of INO-8875 Phase 2b trial against glaucoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.